Back to Results
First PageMeta Content
Affinity maturation / Fusion protein / Hybridoma technology / Immunotoxin / Single-domain antibody / Immune system / Biology / Antibody


Fusogenics™: A novel approach to antibody affinity maturation
Add to Reading List

Document Date: 2013-03-14 08:27:25

Open Document

File Size: 13,87 KB

Share Result on Facebook

City

Winnipeg / /

Company

IgG / Viventia Biotechnologies Inc. / /

Country

Canada / /

IndustryTerm

cancer therapeutics / technology platforms / /

MedicalCondition

grade II astrocytoma / tumor / Pseudomonas / targeted cancer / cancer / disease / specific tumor / breast cancer / /

MedicalTreatment

cancer therapeutics / /

Organization

ETA / /

ProvinceOrState

Manitoba / /

Technology

Fusogenics™ technology / antibodies / /

SocialTag